Showing results (411-420 of 630) with videos related to

Sort By:
Pageof 63
Acta Dermato-Venereologica|May 6, 2024
Targeted Combined Endpoint Improvement in Patient and Disease Domains in Atopic Dermatitis: A Treat-to-Target Analysis of Adults with Moderate-to-Severe Atopic Dermatitis Treated with UpadacitinibShawn G Kwatra, Marjolein De Bruin-Weller, Jonathan I Silverberg, et al.
The Journal of Allergy and Clinical Immunology. in Practice|January 15, 2022
Dupilumab Treatment Reduces Hospitalizations in Adults With Moderate-to-Severe Atopic DermatitisJonathan I Silverberg, Norma P M Rubini, Mario C Pires, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 14, 2018
Severity strata for POEM, PO-SCORAD, and DLQI in US adults with atopic dermatitisJonathan I Silverberg, Joel M Gelfand, David J Margolis, et al.
The Journal of Allergy and Clinical Immunology. in Practice|October 4, 2017
Expert Perspectives on Management of Moderate-to-Severe Atopic Dermatitis: A Multidisciplinary Consensus Addressing Current and Emerging TherapiesMark Boguniewicz, Andrew F Alexis, Lisa A Beck, et al.
The Journal of Dermatological Treatment|April 30, 2020
Dupilumab provides rapid and sustained improvement in SCORAD outcomes in adults with moderate-to-severe atopic dermatitis: combined results of four randomized phase 3 trialsS Barbarot, A Wollenberg, J I Silverberg, et al.
Dermatitis : Contact, Atopic, Occupational, Drug|July 2, 2019
Conceptual Model to Illustrate the Symptom Experience and Humanistic Burden Associated With Atopic Dermatitis in Adults and AdolescentsLaura Grant, Lotte Seiding Larsen, Claire Trennery, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|December 16, 2025
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studiesSonja Ständer, Sarina B Elmariah, Shawn G Kwatra, et al.
Journal of Drugs in Dermatology : JDD|February 23, 2019
Systemic Therapies for Moderate-to-Severe Atopic Dermatitis: Expert Perspectives in PracticeMark Lebwohl, Andrew F. Alexis, Lisa A. Beck, et al.
The Journal of Investigative Dermatology|October 3, 2024
A Scalable Approach to Assess the Safety of Recently Marketed Systemic Treatments for Atopic Dermatitis in Clinical Practice: First Analysis Cycle of a Sequential Monitoring SystemMaria C Schneeweiss, Robert J Glynn, Richard Wyss, et al.
Journal of the American Academy of Dermatology|August 14, 2020
Association between hydrochlorothiazide and the risk of in situ and invasive squamous cell skin carcinoma and basal cell carcinoma: A population-based case-control studyJonas A Adalsteinsson, Sonal Muzumdar, Reid Waldman, et al.
Pageof 63